US › Healthcare

MediciNova Inc (MNOV)

US · Healthcare · Biotechnology

$3.45+36.90%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$458,439

Revenue YoY

+240.6%

Net profit

$-2.3M

EPS

$-0.05

EPS estimate

$-0.06

Net margin

-504.8%

EPS came in at -0.05 against a street estimate of -0.06 — a beat of 16.7%.

Key statistics

Market cap

$89.1M

Forward P/E

8.5

P/B

2.28

Book value

$0.76

EPS (TTM)

$-0.22

52-week high

$1.96

52-week low

$1.17

50-day MA

$1.41

200-day MA

$1.43

Beta

0.63

Analyst view

Analysts rate MediciNova Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $9.00.

Shareholding

Insiders

2.86%

Institutions

10.54%

Largest institutional holders

Fund	Stake
Essex Woodlands Health Ventures	2.25%
BlackRock Inc	1.43%
Citigroup Inc	1.29%
Vanguard Capital Management, LLC	1.24%
Geode Capital Management, LLC	1.10%
Vanguard Fiduciary Trust Co	0.57%
UBS Group AG	0.45%
State Street Corp	0.39%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for MediciNova Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.